sb 203580 has been researched along with syringin in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (syringin) | Trials (syringin) | Recent Studies (post-2010) (syringin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 152 | 0 | 84 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kiem, PV; Kim, ES; Kim, N; Kim, S; Kim, SH; Kim, YH; Koh, YS; Lee, HY; Minh, CV; Nhiem, NX; Park, S | 1 |
1 other study(ies) available for sb 203580 and syringin
Article | Year |
---|---|
Diarylheptanoids and flavonoids from viscum album inhibit LPS-stimulated production of pro-inflammatory cytokines in bone marrow-derived dendritic cells.
Topics: Animals; Anti-Inflammatory Agents; Bone Marrow Cells; Cytokines; Dendritic Cells; Diarylheptanoids; Flavonoids; Glycosides; Inhibitory Concentration 50; Interleukin-12 Subunit p40; Interleukin-6; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Plant Leaves; Plant Stems; Stereoisomerism; Tumor Necrosis Factor-alpha; Viscum album | 2013 |